Interleukin-12. Opportunities for the treatment of bladder cancer. (Q33851149)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Interleukin-12. Opportunities for the treatment of bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S K Clinton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Canto

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

Urologic Clinics of North America

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

147-155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Multiple effects on peripheral hematology following administration of recombinant human interleukin 12 to nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

The toxicology of interleukin-12: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

IL-12 deaths: explanation and a puzzle

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

IL-12 regulates VEGF and MMPs in a murine breast cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Mycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Interleukin-12: a recently discovered cytokine with potential for enhancing cell-mediated immune responses to tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Molecular biology of interleukin-12 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Immunoregulation by interleukin‐12 in MB49.1 tumor‐bearing mice: Cellular and cytokine‐mediated effector mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Interleukin-12 in early or advanced cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Interleukin-12 (IL-12)-driven alloimmune responses in vitro and in vivo: requirement for beta1 subunit of the IL-12 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Inhibition of angiogenesis in vivo by interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Biological function and distribution of human interleukin-12 receptor beta chain

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970242-1

7 January 2021

10.1016/S0094-0143(05)70242-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696253%20AND%20SRC:MED&resulttype=core&format=json